Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -33.54%-38.43M | ---- | 28.68%-28.78M | ---- | -111.66%-40.35M | ---- | 84.85%-19.06M | ---- | 9.53%-125.85M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 1.53%-17.59M | ---- | -8.17%-17.86M | ---- | 1.84%-16.51M | ---- | 0.20%-16.82M | ---- | 48.79%-16.86M |
| Attributable subsidiary (profit) loss | ---- | -96.16%14K | ---- | 250.83%365K | ---- | -31.52%-242K | ---- | 66.48%-184K | ---- | -111.21%-549K |
| Impairment and provisions: | ---- | 75.53%20.98M | ---- | 265.56%11.95M | ---- | 351.66%3.27M | ---- | -101.61%-1.3M | ---- | -49.13%80.63M |
| -Impairment of trade receivables (reversal) | ---- | -124.94%-2.5M | ---- | 1,151.63%10.01M | ---- | --800K | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | --23.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -21.55%1.94M | ---- | 290.07%2.47M | ---- | -101.61%-1.3M | ---- | 2.84%80.63M |
| Revaluation surplus: | ---- | 291.58%3.26M | ---- | -124.53%-1.7M | ---- | 938.38%6.93M | ---- | --667K | ---- | ---- |
| -Other fair value changes | ---- | 291.58%3.26M | ---- | -124.53%-1.7M | ---- | 938.38%6.93M | ---- | --667K | ---- | ---- |
| Asset sale loss (gain): | ---- | --73K | ---- | ---- | ---- | -81.42%21K | ---- | 203.67%113K | ---- | 99.62%-109K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | --73K | ---- | ---- | ---- | -81.42%21K | ---- | 203.67%113K | ---- | ---109K |
| Depreciation and amortization: | ---- | -12.09%7.98M | ---- | -4.75%9.08M | ---- | -19.72%9.53M | ---- | -43.86%11.87M | ---- | -6.67%21.14M |
| -Amortization of intangible assets | ---- | -40.60%1.66M | ---- | -15.77%2.79M | ---- | -0.12%3.31M | ---- | -78.25%3.31M | ---- | -14.17%15.24M |
| Financial expense | ---- | -9.17%3.22M | ---- | -10.51%3.54M | ---- | -11.77%3.96M | ---- | 76.86%4.49M | ---- | 145.83%2.54M |
| Exchange Loss (gain) | ---- | -35.66%2.51M | ---- | -22.39%3.9M | ---- | 263.18%5.03M | ---- | 147.89%1.39M | ---- | -176.48%-2.89M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 162.00%4.18M |
| Operating profit before the change of operating capital | ---- | 7.74%-17.99M | ---- | 31.26%-19.5M | ---- | -50.53%-28.37M | ---- | 50.10%-18.85M | ---- | -121.66%-37.77M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -97.39%31K | ---- | 119.41%1.19M | ---- | 190.17%541K | ---- | -193.75%-600K | ---- | --640K |
| Accounts receivable (increase)decrease | ---- | 70.53%7.63M | ---- | 308.43%4.48M | ---- | 78.11%-2.15M | ---- | -130.85%-9.81M | ---- | 192.98%31.8M |
| Accounts payable increase (decrease) | ---- | 0.83%1.09M | ---- | --1.08M | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | --2.34M | ---- | ---- | ---- | -151.99%-16.37M | ---- | 85.04%31.49M | ---- | 120.22%17.02M |
| Cash from business operations | 37.67%-2.44M | 45.93%-6.9M | 78.87%-3.91M | 72.46%-12.76M | -0.01%-18.52M | -2,181.14%-46.35M | -193.08%-18.52M | -80.93%2.23M | 263.31%19.89M | 108.63%11.68M |
| Other taxs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 138.46%93K | 141.52%93K | 101.81%39K |
| Interest received - operating | -3.03%7.2M | -1.53%17.59M | 210.63%7.42M | 11.75%17.86M | -65.29%2.39M | 14.20%15.99M | 5.10%6.88M | -65.74%14M | -65.29%6.55M | 96.71%40.86M |
| Net cash from operations | 35.60%4.76M | 109.53%10.69M | 121.75%3.51M | 116.80%5.1M | -38.64%-16.13M | -286.08%-30.36M | -143.84%-11.63M | -68.97%16.32M | 10.00%26.53M | 145.02%52.58M |
| Cash flow from investment activities | ||||||||||
| Sale of fixed assets | ---- | --14K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | ---- | 97.14%-17K | ---- | 55.86%-595K | ---- | 7.54%-1.35M | 46.16%-758K | -333.93%-1.46M | ---1.41M | 76.24%-336K |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.92%533K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -249.01%-11.42M |
| Recovery of cash from investments | ---- | ---- | ---- | -54.49%959K | ---- | -49.94%2.11M | ---- | --4.21M | --40K | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | 52.20%-1.99M | ---- | ---4.17M | ---40K | ---- |
| Net cash from investment operations | ---- | -100.82%-3K | ---- | 129.52%364K | ---- | 12.92%-1.23M | 46.16%-758K | 87.38%-1.42M | 87.67%-1.41M | -124.86%-11.22M |
| Net cash before financing | 35.60%4.76M | 95.52%10.69M | 121.75%3.51M | 117.30%5.47M | -30.16%-16.13M | -312.03%-31.6M | -149.31%-12.39M | -63.97%14.9M | 97.76%25.13M | 157.72%41.36M |
| Cash flow from financing activities | ||||||||||
| Interest paid - financing | ---- | 9.17%-3.22M | ---- | 10.51%-3.54M | ---- | 11.77%-3.96M | ---- | -76.86%-4.49M | ---- | -145.83%-2.54M |
| Net cash from financing operations | 27.69%-2.6M | -23.76%-10.85M | 14.49%-3.59M | 29.81%-8.77M | -98.35%-4.2M | -73.02%-12.49M | -1.73%-2.12M | -29.31%-7.22M | -3,154.69%-2.08M | 66.07%-5.58M |
| Effect of rate | ---- | 255.13%3.6M | ---- | -147.51%-2.32M | ---- | 3,093.25%4.88M | ---- | -425.81%-163K | ---- | 95.85%-31K |
| Net Cash | 2,609.30%2.16M | 95.12%-161K | 99.58%-86K | 92.52%-3.3M | -40.12%-20.33M | -673.69%-44.08M | -162.97%-14.51M | -78.52%7.68M | 82.28%23.04M | 140.61%35.78M |
| Begining period cash | 16.45%24.31M | -21.20%20.88M | -21.20%20.88M | -59.67%26.5M | -59.67%26.5M | 12.93%65.7M | 12.93%65.7M | 159.40%58.18M | 159.40%58.18M | -79.85%22.43M |
| Cash at the end | 27.31%26.47M | 16.45%24.31M | 237.22%20.79M | -21.20%20.88M | -87.95%6.17M | -59.67%26.5M | -36.97%51.19M | 12.93%65.7M | 131.81%81.22M | 159.40%58.18M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.